251 related articles for article (PubMed ID: 9847926)
21. [Risks of silicone breast implants unproven].
Nicolai JP
Ned Tijdschr Geneeskd; 1998 Dec; 142(50):2719-20. PubMed ID: 10065234
[TBL] [Abstract][Full Text] [Related]
22. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
Moore TJ; Cohen MR; Furberg CD
Arch Intern Med; 2007 Sep; 167(16):1752-9. PubMed ID: 17846394
[TBL] [Abstract][Full Text] [Related]
23. Medical device reporting: manufacturer reporting, importer reporting, user facility reporting, and distributor reporting--FDA. Direct final rule.
Fed Regist; 1998 May; 63(91):26069-77. PubMed ID: 10179334
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers.
Bennett CL; Nebeker JR; Yarnold PR; Tigue CC; Dorr DA; McKoy JM; Edwards BJ; Hurdle JF; West DP; Lau DT; Angelotta C; Weitzman SA; Belknap SM; Djulbegovic B; Tallman MS; Kuzel TM; Benson AB; Evens A; Trifilio SM; Courtney DM; Raisch DW
Arch Intern Med; 2007 May; 167(10):1041-9. PubMed ID: 17533207
[TBL] [Abstract][Full Text] [Related]
25. Silicone breast implants: lessons from a saga.
Bondurant S
Trans Am Clin Climatol Assoc; 2001; 112():149-56; discussion 157. PubMed ID: 11413774
[TBL] [Abstract][Full Text] [Related]
26. Rupture of a silicone gel mammary prosthesis and amyloidosis: a case report.
Emekli U; Tümerdem B; Demiryont M
Aesthetic Plast Surg; 2002; 26(5):383-7. PubMed ID: 12432480
[TBL] [Abstract][Full Text] [Related]
27. The role of databases in drug postmarketing surveillance.
Rodriguez EM; Staffa JA; Graham DJ
Pharmacoepidemiol Drug Saf; 2001; 10(5):407-10. PubMed ID: 11802586
[TBL] [Abstract][Full Text] [Related]
28. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007.
Gubernot DM; Lucey CT; Lee KC; Conley GB; Holness LG; Wise RP
Clin Infect Dis; 2009 Jan; 48(1):25-30. PubMed ID: 19035776
[TBL] [Abstract][Full Text] [Related]
29. Dietary supplement adverse event reports: review and analysis.
Talati AR; Gurnani AK
Food Drug Law J; 2009; 64(3):503-13. PubMed ID: 19999641
[TBL] [Abstract][Full Text] [Related]
30. Improving patient care by reporting problems with medical devices.
White GG; Weick-Brady MD; Goldman SA; Gross TP; Kennedy DL; Lucas BS; Merritt K; Naschinski C
CRNA; 1998 Nov; 9(4):139-56. PubMed ID: 9866489
[TBL] [Abstract][Full Text] [Related]
31. Silicone breast implants. An argument for science.
Veal S
AAOHN J; 1998 Nov; 46(11):537-46. PubMed ID: 9934002
[No Abstract] [Full Text] [Related]
32. Silicone breast implant rupture presenting as bilateral leg nodules.
Sagi L; Baum S; Lyakhovitsky A; Barzilai A; Shpiro D; Trau H; Goldan O; Winkler E
Clin Exp Dermatol; 2009 Jul; 34(5):e99-101. PubMed ID: 19438562
[TBL] [Abstract][Full Text] [Related]
33. Medical devices; medical device reporting; baseline reports. Direct final rule.
Food and Drug Administration, HHS
Fed Regist; 2008 Jun; 73(115):33692-5. PubMed ID: 18677824
[TBL] [Abstract][Full Text] [Related]
34. Reevaluating the safety profile of pediatrics: a comparison of computerized adverse drug event surveillance and voluntary reporting in the pediatric environment.
Ferranti J; Horvath MM; Cozart H; Whitehurst J; Eckstrand J
Pediatrics; 2008 May; 121(5):e1201-7. PubMed ID: 18450863
[TBL] [Abstract][Full Text] [Related]
35. Form for reporting serious adverse events and product problems with human drug and biological products and devices; availability--FDA. Notice.
Fed Regist; 1993 Jun; 58(105):31596-614. PubMed ID: 10171452
[TBL] [Abstract][Full Text] [Related]
36. Medical device surveillance: gender differences in pulmonary artery rupture after pulmonary artery catheterization.
Kaczmarek RG; Liu CH; Gross TP
J Womens Health (Larchmt); 2003 Nov; 12(9):931-5. PubMed ID: 14670173
[TBL] [Abstract][Full Text] [Related]
37. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and Food and Drug Administration regulatory actions.
Wysowski DK; Corken A; Gallo-Torres H; Talarico L; Rodriguez EM
Am J Gastroenterol; 2001 Jun; 96(6):1698-703. PubMed ID: 11419817
[TBL] [Abstract][Full Text] [Related]
38. National adverse drug reaction reporting. 1984-1989.
Faich GA
Arch Intern Med; 1991 Aug; 151(8):1645-7. PubMed ID: 1872669
[TBL] [Abstract][Full Text] [Related]
39. Commentary: are breast implants safe?
Zuckerman D
MedGenMed; 2001 Oct; 3(4):12. PubMed ID: 11698919
[No Abstract] [Full Text] [Related]
40. Evaluation of efficacy of heartworm preventive products at the FDA.
Hampshire VA
Vet Parasitol; 2005 Oct; 133(2-3):191-5. PubMed ID: 16099105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
